Publications


Publications
High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv

Tuberculosis

Ananthan S, Faaleolea ER, Goldman RC, Hobrath JV, Kwong CD, Laughon BE, Maddry JA, Mehta A, Rasmussen L, Reynolds RC, Secrist JA, Shindo N, Showe DN, Sosa MI, Suling WJ, White EL
Tuberculosis - vol. 89 334-353 (2009)

There is an urgent need for the discovery and development of new antitubercular agents that target new biochemical pathways and treat drug resistant forms of the disease. One approach to addressing this need is through high-throughput screening of medicinally relevant libraries against the whole bacterium in order to discover a variety of new, active scaffolds […]

Publications
Inhibiting the calcineurin-NFAT (nuclear factor of activated T cells) signaling pathway with a regulator of calcineurin-derived peptide without affecting general calcineurin phosphatase activity

Journal of Biological Chemistry

Journal of Biological Chemistry - vol. 284 9394-9401 (2009)

Calcineurin phosphatase plays a crucial role in T cell activation. Dephosphorylation of the nuclear factors of activated T cells (NFATs) by calcineurin is essential for activating cytokine gene expression and, consequently, the immune response. Current immunosuppressive protocols are based mainly on calcineurin inhibitors, cyclosporine A and FK506. Unfortunately, these drugs are associated with severe side […]

Publications
A basis for reduced chemical library inhibition of firefly luciferase obtained from directed evolution

Journal of Medicinal Chemistry

Auld DS, Zhang YQ, Southall NT, Rai G, Landsman M, MacLure J, Langevin D, Thomas CJ, Austin CP, Inglese J
Journal of Medicinal Chemistry - vol. 52 1450-1458 (2009)

We measured the « druggability » of the ATP-dependent luciferase derived from the firefly Photuris pennsylvanica that was optimized using directed evolution (Ultra-Glo, Promega). Quantitative high-throughput screening (qHTS) was used to determine IC(50)s of 198899 samples against a formulation of Ultra-Glo luciferase (Kinase-Glo). We found that only 0.1% of the Kinase-Glo inhibitors showed an IC(50) < 10 […]

Publications
Monitoring Compound Integrity with cytochrome P450 assays and qHTS

Www.Sbsonline.Org

MacArthur R, Leister W, Veith H, Shinn P, Southall N, Austin CP, Inglese J, Auld DS
Www.Sbsonline.Org 1-9 (2009)

The authors describe how room temperature storage of a 1120-member compound library prepard in either DMSO or in a hydrated-DMSO/water (67/33) mixture affects the reproducibility of potency values as monitored using cytochrome P450 1A2 and 2D6 isozyme assays. The bioluminescent assays showed Z’factors of 0.71 and 0.62, with 17% and 32% of the library found […]

Publications
A small molecule that directs differentiation of human ESCs into the pancreatic lineage.

Nature chemical biology

Chen S, Borowiak M, Fox JL, Maehr R, Osafune K, Davidow L, Lam K, Peng LF, Schreiber SL, Rubin LL, Melton D
Nature chemical biology - vol. 5 258-265 (2009)

Stepwise differentiation from embryonic stem cells (ESCs) to functional insulin-secreting beta cells will identify key steps in beta-cell development and may yet prove useful for transplantation therapy for diabetics. An essential step in this schema is the generation of pancreatic progenitors–cells that express Pdx1 and produce all the cell types of the pancreas. High-content chemical […]

Publications
Parallel RNAi and compound screens identify the PDK1 pathway as a target for tamoxifen sensitization.

The Biochemical journal

Iorns E, Lord CJ, Ashworth A
The Biochemical journal - vol. 417 361-370 (2009)

Tamoxifen is the most commonly used drug to treat breast cancer and acts by blocking ERalpha (oestrogen receptor alpha) signalling. Although highly effective, its usefulness is limited by the development of resistance. Given this, strategies that limit resistance by sensitizing cells to tamoxifen may be of use in the clinic. To gain insight into how […]

Publications
Selective 5-hydroxytryptamine 2c receptor agonists derived from the lead compound tranylcypromine: Identification of drugs with antidepressant-like action

Journal of Medicinal Chemistry

Sung JC, Jensen NH, Kurome T, Kadari S, Manzano ML, Malberg JE, Caldarone B, Roth BL, Kozikowski AP
Journal of Medicinal Chemistry - vol. 52 1885-1902 (2009)

We report here the design, synthesis, and pharmacological properties of a series of compounds related to tranylcypromine (9), which itself was discovered as a lead compound in a high-throughput screening campaign. Starting from 9, which shows modest activity as a 5-HT(2C) agonist, a series of 1-aminomethyl-2-phenylcyclopropanes was investigated as 5-HT(2C) agonists through iterative structural modifications. […]

Publications
Parallel Functional Activity Profiling Reveals Valvulopathogens Are Potent 5-Hydroxytryptamine 2B Receptor Agonists : Implications for Drug Safety Assessment □

Molecular Pharmacology

Huang X, Setola V, Yadav PN, Allen JA, Rogan SC, Hanson BJ, Revankar C, Robers M, Doucette C, Roth BL
Molecular Pharmacology - vol. 5 710-722 (2009)

Drug-induced valvular heart disease (VHD) is a serious side effect of a few medications, including some that are on the market. Pharmacological studies of VHD-associated medications (e.g., fenfluramine, pergolide, methysergide, and cabergoline) have revealed that they and/or their metabolites are potent 5-hydroxytryptamine2B (5-HT2B) receptor agonists. We have shown that activation of 5-HT2B receptors on human […]

Publications
French/European academic compound library initiative

Drug Discovery Today

Hibert MF
Drug Discovery Today - vol. 14 723-725 (2009)

Since the year 2000, French academic medicinal chemists took the initiative to collect molecules and natural extracts produced in their labs over the past years to catalyse scientific partnerships with biologists through virtual and experimental screening. This formatted collection was named ‘Chimiothe`que Nationale’ (National Compound Library). After eight years of existence, the outcome in terms […]

Publications
Establishment of human papillomavirus infection requires cell cycle progression

PLoS Pathogens

Pyeon D, Pearce SM, Lank SM, Ahlquist P, Lambert PF
PLoS Pathogens - vol. 5 (2009)

Human papillomaviruses (HPVs) are DNA viruses associated with major human cancers. As such there is a strong interest in developing new means, such as vaccines and microbicides, to prevent HPV infections. Developing the latter requires a better understanding of the infectious life cycle of HPVs. The HPV infectious life cycle is closely linked to the […]